Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism

ClinicalTrials.gov ID: NCT05712421

Public ClinicalTrials.gov record NCT05712421. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Dose-Conversion Study to Evaluate the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Subjects With Primary Hypothyroidism Who Are Euthyroid on Levothyroxine Replacement Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The North Star study is a multi-center, Phase 2, double-blind, randomized, parallel group clinical study to evaluate the safe and effective dose conversion from Levothyroxine to North Star therapy.

Study identification

NCT ID
NCT05712421
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neuvosyn Laboratories, LLC
Industry
Enrollment
303 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2023 (Actual)
Primary completion
May 5, 2025 (Actual)
Completion
Sep 18, 2025 (Actual)
Last update posted
Feb 18, 2026

2023 – 2025

United States locations

U.S. sites
31
U.S. states
11
U.S. cities
26
Facility City State ZIP Site status
Neuvosyn Investigational Site Birmingham Alabama 35209 —
Neuvosyn Investigational Site Canoga Park California 91304 —
Neuvosyn Investigational Site Greenbrae California 94904 —
Neuvosyn Investigational Site Toluca Lake California 91602 —
Neuvosyn Investigational Site Farmington Connecticut 06030 —
Neuvosyn Investigational Site Boca Raton Florida 33434 —
Neuvosyn Investigational Site Miami Florida 33144 —
Neuvosyn Investigational Site Miami Florida 33145 —
Neuvosyn Investigational Site Miami Florida 33155 —
Neuvosyn Investigational Site Miami Florida 33174 —
Neuvosyn Investigational Site Miami Florida 33179 —
Neuvosyn Investigational Site Sunrise Florida 33351 —
Neuvosyn Investigational Site Acworth Georgia 30101 —
Neuvosyn Investigational Site Atlanta Georgia 30318 —
Neuvosyn Investigational Site Columbus Georgia 31904 —
Neuvosyn Investigational Site Sugar Hill Georgia 30024 —
Neuvosyn Investigational Site Saginaw Michigan 48602 —
Neuvosyn Investigational Site Gladstone Missouri 64118 —
Neuvosyn Investigational Site Williamsville New York 14221 —
Neuvosyn Investigational Site Denver North Carolina 28037 —
Neuvosyn Investigational Site Winston-Salem North Carolina 27103 —
Neuvosyn Investigational Site Beavercreek Ohio 45440 —
Neuvosyn Investigational Site Columbus Ohio 31904 —
Neuvosyn Investigational Site Georgetown Texas 78628 —
Neuvosyn Investigational Site Houston Texas 77040 —
Neuvosyn Investigational Site Katy Texas 77450 —
Neuvosyn Investigational Site Katy Texas 77494 —
Neuvosyn Investigational Site Lewisville Texas 75067 —
Neuvosyn Investigational Site Paris Texas 75462 —
Neuvosyn Investigational Site Pearland Texas 77584 —
Neuvosyn Investigational Site Stafford Texas 77477 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05712421, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05712421 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →